http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007069033-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf142cf2e052f9d5eff21a010d558fbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e11f76f47963639d05c45b99ff7e6eb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 2006-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fe24122ed6c60b5f8db1b1a328dbea2
publicationDate 2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007069033-A3
titleOfInvention Pharmaceutical compositions comprising dexibuprofen, an opiate analgesic and paracetamol
abstract A pharmaceutical composition including a combination of a sub-therapeutic amount of the S isomer of ibuprofen, also referred to as dexibuprofen, or a pharmaceutically acceptable salt or derivative thereof, an opiate or a pharmaceutically acceptable salt or derivative thereof, and a centrally-acting cyclo-oxygenase inhibitor, as active ingredients, and a pharmaceutically acceptable carrier. A typical combination includes paracetamol, dexibuprofen and codeine, with the dexibuprofen being provided in an amount to give a daily dose of 100 mg or less. A method of treatment using a combination of a sub-therapeutic amount of dexibuprofen, an opiate and a centrally-acting cyclo-oxygenase inhibitor is also described.
priorityDate 2005-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5164398-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9605834-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006004449-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-605538-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39912

Total number of triples: 28.